The pharmaceutical logistics market size is expected to see strong growth in the next few years. It will grow to $156.08 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing investments in smart cold chain infrastructure, rising demand for specialty drug distribution, expansion of digital supply chain platforms, growing focus on sustainability in logistics, increasing use of predictive analytics for inventory management. Major trends in the forecast period include increasing adoption of cold chain monitoring solutions, rising demand for temperature-controlled transportation, expansion of real-time logistics tracking platforms, growing focus on end-to-end supply chain visibility, integration of automated warehousing systems.
The increase in healthcare expenditure is expected to drive the growth of the pharmaceutical logistics market in the coming years. Healthcare expenditure represents the total financial resources spent by individuals, organizations, or governments on healthcare-related goods and services over a given period. Higher healthcare spending supports the advancement of pharmaceutical logistics by enabling investment in modern supply chain technologies, ensuring secure and timely delivery of medicines, and improving overall efficiency in distribution networks. For instance, in April 2025, according to the American Medical Association, a US-based professional association, health spending in the United States increased by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per person, compared with a growth rate of 4.6% in 2022. Therefore, rising healthcare expenditure is contributing to the growth of the pharmaceutical logistics market.
Major companies operating in the pharmaceutical logistics market are focusing on introducing innovative healthcare logistics services to expand their customer base, enhance operational efficiency, and increase revenue. Healthcare logistics services involve the planning, execution, and management of the secure and efficient movement of healthcare products, equipment, and related information across the supply chain. For example, in October 2023, UPS Healthcare, a US-based healthcare logistics provider, launched UPS Pickup Point locations. These locations offer a reverse logistics solution designed for health laboratory customers across the UK, Germany, Italy, France, and Spain. The service provides confirmation of collection and real-time visibility for time-sensitive specimens, streamlining operations by reducing the number of collection sites while improving reliability, control, and efficient transport of samples to centralized laboratories.
In November 2024, Lakeside Holding Limited, a China-based logistics and supply chain company, acquired Hupan Pharmaceutical (Hubei) Co. Ltd. for an undisclosed amount. Through this acquisition, Lakeside aims to enter the pharmaceutical logistics sector by integrating Hupan’s pharmaceutical distribution and supply chain capabilities, including drug wholesale and third-class medical device distribution. This move enables Lakeside to expand into medical logistics and strengthen its ability to distribute critical medicines and medical products across China. Hupan Pharmaceutical (Hubei) Co., Ltd. is a China-based company specializing in pharmaceutical distribution and supply chain services.
Major companies operating in the pharmaceutical logistics market are McKesson Corporation, AmerisourceBergen Corp, Cardinal Health Inc., Deutsche Post AG, FedEx Corp, Kuehne + Nagel International AG, SF Holding Co Ltd., CR Pharmaceutical Group Ltd., DSV Panalpina A/S, Schenker AG, C.H. Robinson Worldwide Inc., Alfresa Holdings Corp, Nippon Express Co Ltd., Kerry Logistics Network Limited, Lineage Logistics Holding LLC., Flexport Inc., Nichirei Logistics Group Inc., Mainfreight Ltd., Americold Logistics LLC., NFI Industries Inc., Agility Public Warehousing Company K.S.C.P., Profarma Distribuidora de Produtos Farmaceuticos S.A., United States Cold Storage Inc., NewCold Advanced Cold Logistics BV, Cloverleaf Cold Storage Co, Kingworld Medicines Group Ltd, CEVA Logistics AG, Kloosterboer Group BV., MEDIPAL HOLDINGS Corp, B.C. Ice & Cold Storage Co.
North America was the largest region in the pharmaceutical logistics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the pharmaceutical logistics market by increasing costs of imported refrigeration units, temperature sensors, monitoring devices, specialized packaging materials, and transport equipment used in cold chain logistics. North America and Europe are most affected due to dependence on imported monitoring technologies, while Asia-Pacific faces higher costs in expanding export-oriented cold chain networks. These tariffs are raising logistics service costs and affecting distribution margins. However, they are also encouraging domestic manufacturing of cold chain equipment, regional infrastructure investments, and adoption of optimized logistics technologies.
The pharmaceutical logistics market research report is one of a series of new reports that provides pharmaceutical logistics market statistics, including pharmaceutical logistics industry global market size, regional shares, competitors with a pharmaceutical logistics market share, detailed pharmaceutical logistics market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical logistics industry. This pharmaceutical logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pharmaceutical logistics involves the coordination of information flow, material handling, production, packaging, inventory management, and supply chain operations for prescription medicines. It is a vital part of the healthcare supply chain, concentrating on the proper storage, handling, and transportation of pharmaceutical products to ensure safety, quality, and timely delivery.
The primary types of pharmaceutical logistics include cold chain logistics and non-cold chain logistics. Cold chain logistics refers to the technologies and processes used to safely transport temperature-sensitive pharmaceutical products throughout the supply chain. Key components of pharmaceutical logistics include storage, transportation, and monitoring systems. Operational procedures encompass picking, storage, retrieval, and handling systems, while transportation modes include sea freight, air freight, and overland transport. These logistics solutions support applications across biopharmaceuticals, chemical pharmaceuticals, and specialty pharmaceuticals.
The pharmaceutical logistics market includes revenues earned by entities by providing cold chain storage, asset ownership services, and quality management systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Pharmaceutical Logistics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pharmaceutical logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pharmaceutical logistics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical logistics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Cold Chain Logistics; Non-Cold Chain Logistics2) By Component: Storage; Transportation; Monitoring Components
3) By Procedure: Picking; Storage; Retrieval Systems; Handling Systems
4) By Transportation: Sea Freight; Air Freight; Overland
5) By Application: Bio Pharma; Chemical Pharma; Specialty Pharma
Subsegments:
1) By Cold Chain Logistics: Refrigerated Transport; Temperature-Controlled Warehousing; Cold Chain Monitoring Systems; Packaging Solutions For Cold Chain2) By Non-Cold Chain Logistics: Standard Transport Services; Ambient Warehousing; General Packaging Solutions; Supply Chain Management Services
Companies Mentioned: McKesson Corporation; AmerisourceBergen Corp; Cardinal Health Inc.; Deutsche Post AG; FedEx Corp; Kuehne + Nagel International AG; SF Holding Co Ltd.; CR Pharmaceutical Group Ltd.; DSV Panalpina A/S; Schenker AG; C.H. Robinson Worldwide Inc.; Alfresa Holdings Corp; Nippon Express Co Ltd.; Kerry Logistics Network Limited; Lineage Logistics Holding LLC.; Flexport Inc.; Nichirei Logistics Group Inc.; Mainfreight Ltd.; Americold Logistics LLC.; NFI Industries Inc.; Agility Public Warehousing Company K.S.C.P.; Profarma Distribuidora de Produtos Farmaceuticos S.A.; United States Cold Storage Inc.; NewCold Advanced Cold Logistics BV; Cloverleaf Cold Storage Co; Kingworld Medicines Group Ltd; CEVA Logistics AG; Kloosterboer Group BV.; MEDIPAL HOLDINGS Corp; B.C. Ice & Cold Storage Co
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pharmaceutical Logistics market report include:- McKesson Corporation
- AmerisourceBergen Corp
- Cardinal Health Inc.
- Deutsche Post AG
- FedEx Corp
- Kuehne + Nagel International AG
- SF Holding Co Ltd.
- CR Pharmaceutical Group Ltd.
- DSV Panalpina A/S
- Schenker AG
- C.H. Robinson Worldwide Inc.
- Alfresa Holdings Corp
- Nippon Express Co Ltd.
- Kerry Logistics Network Limited
- Lineage Logistics Holding LLC.
- Flexport Inc.
- Nichirei Logistics Group Inc.
- Mainfreight Ltd.
- Americold Logistics LLC.
- NFI Industries Inc.
- Agility Public Warehousing Company K.S.C.P.
- Profarma Distribuidora de Produtos Farmaceuticos S.A.
- United States Cold Storage Inc.
- NewCold Advanced Cold Logistics BV
- Cloverleaf Cold Storage Co
- Kingworld Medicines Group Ltd
- CEVA Logistics AG
- Kloosterboer Group BV.
- MEDIPAL HOLDINGS Corp
- B.C. Ice & Cold Storage Co
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 113.41 Billion |
| Forecasted Market Value ( USD | $ 156.08 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |


